Title : Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.

Pub. Date : 2001 Nov 16

PMID : 11720428






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy. Epirubicin colony stimulating factor 3 Homo sapiens
2 None of the patients encountered dose-limiting toxicity in the first course, which confirmed that epirubicin 135 mg m(-2) could be combined with cisplatin 60 mg m(-2) and accelerated by G-CSF support to a 14-day-schedule. Epirubicin colony stimulating factor 3 Homo sapiens
3 Accelerated cisplatin and high-dose epirubicin with G-CSF support is a feasible and promising regimen in relapsed NSCLC. Epirubicin colony stimulating factor 3 Homo sapiens